Gene Z. Salkind - 17 Aug 2023 Form 4 Insider Report for Avenir Wellness Solutions, Inc. (AVRW)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
21 Aug 2023, 21:50:19 UTC
Prior SEC filing
21 Aug 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gene Z. Salkind

Key filing fact

Gene Z. Salkind filed Form 4 for Avenir Wellness Solutions, Inc. (AVRW) on 21 Aug 2023.

Key facts

  • This page summarizes Gene Z. Salkind's Form 4 filing for Avenir Wellness Solutions, Inc. (AVRW).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 21 Aug 2023, 21:50.

Change

  • Previous filing in this sequence was filed on 21 Aug 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVRW transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+186,364
Change %
+46%
Price
$0.000000
Shares after
589,685
Date
17 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
186,364
Exercise price
$0.1100
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan pursuant to the Issuer's Non-Employee Director Compensation Policy. The RSUs will vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service through the vesting date. The RSUs will vest in full immediately prior to the consummation of a change in control of the Issuer. The RSUs will be settled in shares of the Issuer's common stock upon vesting.

Footnote F2

N/A

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .